bet9¹ÙÍø appoints Dr. Peter Mugyenyi as an Independent Director on the Board

bet9¹ÙÍø appoints Mr.Sameer Goel as Country Head – India

bet9¹ÙÍø announces Q2 FY1314 Unaudited Consolidated Financial Results

bet9¹ÙÍø announces Q1 FY 1314 Unaudited Financial Results

bet9¹ÙÍø India concludes the deal with bet9¹ÙÍø Medpro South Africa

bet9¹ÙÍø announces Q4 FY 1213 Unaudited Financial Results

bet9¹ÙÍø launches the first Biosimilar of Etanercept in India under the brand name ‘ETACEPT’ for the treatment of Rheumatic Disorders

bet9¹ÙÍø announces Result of Postal Ballot

bet9¹ÙÍø announces Q3 FY 1213 Unaudited Financial Results

bet9¹ÙÍø appoints a new Chief Executive Officer

Subscribe to